QIAGEN Launches Fourth-generation QuantiFERON®-TB Gold Plus in the U.S.
GERMANTOWN, Maryland and HILDEN, Germany, October 5, 2017 /PRNewswire/ --
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth generation of its leading blood test for tuberculosis (TB) infection. QFT-Plus kits will be available on October 9, 2017 for diagnostic use following U.S. Food and Drug Administration approval in June.
QFT-Plus advances the science of TB testing with innovative antigens that measure the cell-mediated immune response to tuberculosis infection from both CD4+ and CD8+ T cells - providing a broader assessment of TB infection. CD8+ T cells have been shown to play an important role in Mycobacterium tuberculosis immunity.
The "Digital Banking - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Digital Banking estimated at US$21.1 Billion in the year 2023, is projected to reach a revised size of US$53.5...
NASA is awarding approximately $3.7 million to 17 museums, science centers, and other informal education institutions as part of an initiative to ignite STEM excitement. The money will go toward projects that inspire students and their learning...
Epiq, a global technology-enabled leader to the legal industry and corporations, announced today Epiq Facilitatortm the premier, reliable, secure application for retrieving information, managing legal analysis, and administering voluntary...
The "Industrial Ovens - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Industrial Ovens estimated at US$10.8 Billion in the year 2023, is projected to reach a revised size of US$14.8...
CrowdStrike announced the winners of the annual CrowdStrike Asia Pacific and Japan (APJ) Partner Awards at the CrowdStrike Partner Symposium in Bangkok.
The awards recognize the exceptional work the partner ecosystem accomplished, supporting...